You are here

  • Home
  • Archive
  • Volume 4, Issue 1
  • Systemic versus local responses in melanoma patients treated with talimogene laherparepvec from a multi-institutional phase II study

Article metrics

Article menu

Download PDFPDF

Research Article
Systemic versus local responses in melanoma patients treated with talimogene laherparepvec from a multi-institutional phase II study

 

Online download statistics by month:

Online download statistics by month: December 2019 to October 2024

AbstractFullPdf
Dec 2019330
Jan 2020330
Feb 202018187
Mar 202015153
Apr 202010101
May 202020207
Jun 202015151
Jul 2020991
Aug 202011110
Sep 202032323
Oct 202021212
Nov 202028287
Dec 202017171
Jan 202119192
Feb 202119196
Mar 202122222
Apr 202117173
May 202110105
Jun 202116164
Jul 202119193
Aug 202112123
Sep 202116168
Oct 202116166
Nov 2021762
Dec 202120202
Jan 202217181
Feb 2022885
Mar 202220204
Apr 202216173
May 202222223
Jun 202225271
Jul 202243431
Aug 202242425
Sep 202224234
Oct 202225258
Nov 2022181912
Dec 202223234
Jan 202332333
Feb 202341411
Mar 202328322
Apr 202312135
May 202313135
Jun 2023662
Jul 2023191911
Aug 202314144
Sep 20231261263
Oct 20231301305
Nov 20232322321
Dec 202355553
Jan 202414152
Feb 202426261
Mar 202413133
Apr 202431312
May 202413131
Jun 202426276
Jul 202433345
Aug 202421188
Sep 202417165
Oct 2024282812
Total16081616220